Temple of Heaven Biology: Optimistic about the revitalization of biological Industry planning

Premier Wen Jiabao 13th chaired the State Council executive meeting to discuss and adopt the principles of promoting the development of the biological industry in several policies.　　The state will focus on biomedicine, bio-agriculture, bioenergy, bio-manufacturing and bio-environmental protection industries and vigorously develop modern biological industries. At present, the development of the biological industry is becoming more and more noticeable. Can bio-industry become a new growth point of China's economy? How can biological enterprises compete effectively?　　These problems have become the focus of people's attention. The Temple of Heaven Bio-optimistic bio-industry revitalization policy the Temple of Biology as a leading enterprise in the biopharmaceutical industry, a senior person in the company told reporters that this country-level policy will have a good role in promoting the biological industry, and should follow the supporting funds.　　Temple of Heaven Life is more in line with the spirit of the document business, I believe will also benefit. He said that the document is more practical, even specific diseases can be mentioned, such as AIDS and viral hepatitis, which indicates that the national attention to the prevention of infectious diseases is continuing to strengthen. Although not yet seen any specific details, but he believes that this policy has a "point" on the breakthrough-to enhance the strength of the leading enterprises, but also a "face" on the development of the establishment of small and medium-sized enterprises base. 　　Both macro-level statements, but also the operation of the guidance. He said, "At present, this policy will certainly affect the industry, will be more than the Chinese biotechnology group, such as the impact of a large enterprise, for our member companies, the direct impact of the analysis is not good." However, we are an important supplier of hepatitis B vaccine, and the policy will bring us some business opportunities in this area, which will expand the market capacity of such products to some extent. At present, the AIDS vaccine belongs to our company's research project, the policy may increase the project research and development strength.　　"We should create the conditions for the introduction of venture capital into the bio-industry." However, some professionals expressed concern that the shortage of funds and financing difficulties seriously restricted the development of China's biological industry. "Breakthroughs in the biotech industry require support from a variety of factors such as talent, technology, capital and the environment, and the market has great potential," said Liu Yanming, analyst at Galaxy Securities. But now we lack the integration ability to integrate factors, our science and technology enterprises do not show their technological innovation ability, no innovative results, and the lack of corresponding protection in intellectual property rights. Therefore, our soft environment needs to be further improved. "He believes that to break this bottleneck, the urgent need for venture capital intervention." "China's biotechnology needs the most risk-investment support in the proportion of 49.6%, the other in turn are government funds, pharmaceutical companies, international funds." ”